<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="relies on a solid theoretical understanding of the mechanisms of" exact="SARS-CoV-2 infection" post="and host responses, which is coupled to the practical"/>
 <result pre="appear to be the ideal candidate for the treatment of" exact="SARS-CoV-2 infection." post="AT1R antagonists counterbalance the negative consequences of angiotesnin II"/>
 <result pre="past epidemics such as severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS), as well as the current emerging SARS-CoV-2 pandemic."/>
 <result pre="seem to be the ideal candidate for the treatment of" exact="SARS-CoV-2 infection." post="AT1R antagonists counterbalance the negative consequences of AngII and"/>
 <result pre="discussion about the role of the reninâ€&quot;angiotensin system (RAS) in" exact="SARS-CoV-2 infection." post="Some authors claim that the use of ACE inhibitors"/>
 <result pre="to the observation that among the more severe cases of" exact="SARS-CoV-2 infection," post="a larger number of individuals had hypertension and diabetes.2â€&quot;5"/>
 <result pre="the inflammatory response. Therefore, it is suggested that, during active" exact="SARS-CoV-2 infection," post="AT1R-mediated ACE2 destruction plays a deleterious role, promoting both"/>
 <result pre="disruptions of these organs. It has been shown that the" exact="SARS-CoV-2 infection" post="was related to active myocardial injury, myocardial stress, and"/>
 <result pre="higher AngII levels, due to the disrupted ACE2 by the" exact="SARS-CoV-2 infection," post="it was recently shown that this was associated with"/>
 <result pre="observed higher values of D-dimer and cardiovascular thrombotic events.35 Treating" exact="SARS-CoV-2 infection" post="with AT1R antagonists Following the above, SARS-CoV-2 infection by"/>
 <result pre="events.35 Treating SARS-CoV-2 infection with AT1R antagonists Following the above," exact="SARS-CoV-2 infection" post="by binding to ACE2 disrupts the normal AngII:ACE2 balance,"/>
 <result pre="side effects, which make them the ideal treatment option for" exact="SARS-CoV-2 infection." post="We are not the only ones suggesting this hypothesis;"/>
 <result pre="antagonist may completely prevent the excessive inflammation related to the" exact="SARS-CoV-2 infection," post="by restoring ACE2 function and thereby preventing viral load"/>
 <result pre="chloroquine appears to be unsuitable for the treatment of a" exact="SARS-CoV-2 infection," post="whereas it could play a modest role in its"/>
 <result pre="with regard to their relationship with the severity of the" exact="SARS-CoV-2 infection." post="A recent article by Zhang et al. showed that"/>
 <result pre="that among 1128 hypertensive individuals admitted to hospital because of" exact="SARS-CoV-2 infection," post="individuals using either ACEIs or an AT1R antagonist were"/>
 <result pre="double-blind, placebo-controlled randomized Losartan 25 mg o.d. Placebo Non-hospitalized Proven" exact="SARS-CoV-2 infection" post="Cough, rhinorrhea, or fever Admission to hospital 580 Yes"/>
 <result pre="double-blind, placebo-controlled randomized Losartan 50 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="Respiratory failure Difference in estimated (PEEP adjusted) P/F ratio"/>
 <result pre="to 50 mg o.d. day 3 Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Respiratory failure Adverse event due to losartan 50 Yes"/>
 <result pre="100 mg/asprin 150 mg/simvastatin 80 mg o.d. Comparison Hospitalized Suspected" exact="SARS-CoV-2 infection" post="Fever, cough, hypoxia 28 day death 10 000 No"/>
 <result pre="placebo-controlled, randomized comparison Losartan 25 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="NCOSS scores 4000 Yes NCT04340557 Sharp HealthCare Multicentre open"/>
 <result pre="label, randomized Losartan 12.5 mg t.i.d Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Requiring oxygen ICU admission for mechanical ventilation 200 Yes"/>
 <result pre="Clinical trial, factorial, randomized Losartan 25 mg o.d. Comparison Proven" exact="SARS-CoV-2 infection" post="Improvement in FMTVDM measurement with nuclear imaging. 500 Enrolling"/>
 <result pre="label, randomized Candesartan 4 mg o.d. Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Sustained improvement (&amp;gt;48 h) of one point on the"/>
 <result pre="label, randomized Telmisartan 80 mg t.d. Standard care Hospitalized Proven" exact="SARS-CoV-2 infection" post="Need for supplementary oxygen 400 Yes NCT04335786 Radboud University"/>
 <result pre="mg titrated up to 160 mg o.d. Placebo Hospitalized Proven" exact="SARS-CoV-2 infection" post="Admission to the ICU for mechanical ventilation or death"/>
 <result pre="label, randomized Telmisartan 20 mg o.d. Vitamin complex Non-hospitalized Proven" exact="SARS-CoV-2 infection" post="Age â‰¥ 65 years Proportion of participants with an"/>
 <result pre="China Medical Treatment Expert Group for Covid-19. Clinical characteristics of" exact="coronavirus disease 2019" post="in China. N Engl J Med2020;382:1708â€&quot;1720.32109013 3HuangC, WangY, LiX,"/>
 <result pre="LiD, SunZ.Anticoagulant treatment is associated with decreased mortality in severe" exact="coronavirus disease 2019" post="patients with coagulopathy. J Thromb Haemost2020;18:1094â€&quot;1099.32220112 36WangF, XiaZF, ChenXL,"/>
</results>
